Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane …
EJ van Zuuren, Z Fedorowicz, E Pucci… - Journal of Neurology …, 2014 - jnnp.bmj.com
Background It has been recently hypothesised that chronic cerebrospinal venous
insufficiency (CCSVI) may be an important factor in the pathogenesis of multiple sclerosis …
insufficiency (CCSVI) may be an important factor in the pathogenesis of multiple sclerosis …
“Liberation treatment” for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free
Background Chronic cerebrospinal venous insufficiency (CCSVI) has recently been
introduced as a chronic state of impaired cerebral or cervical venous drainage that may be …
introduced as a chronic state of impaired cerebral or cervical venous drainage that may be …
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial
Importance Chronic cerebrospinal venous insufficiency (CCSVI) is characterized by
restricted venous outflow from the brain and spinal cord. Whether this condition is …
restricted venous outflow from the brain and spinal cord. Whether this condition is …
Multiple sclerosis and chronic cerebrospinal venous insufficiency: a critical review
AM Awad, E Marder, R Milo… - Therapeutic Advances in …, 2011 - journals.sagepub.com
Chronic cerebrospinal venous insufficiency (CCSVI) was recently proposed as a
contributing factor in the pathology of multiple sclerosis. This concept has gained …
contributing factor in the pathology of multiple sclerosis. This concept has gained …
Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case–control studies
G Tsivgoulis, TN Sergentanis, A Chan… - Therapeutic …, 2014 - journals.sagepub.com
Objectives: Chronic cerebrospinal venous insufficiency (CCSVI) has recently been
implicated in the pathogenesis of multiple sclerosis (MS). This comprehensive meta-analysis …
implicated in the pathogenesis of multiple sclerosis (MS). This comprehensive meta-analysis …
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients
EJ van Zuuren, Z Fedorowicz, E Pucci… - Cochrane Database …, 2012 - cochranelibrary.com
Background Multiple sclerosis (MS) is a leading cause of neurological disability in young
adults. The most widely accepted hypothesis regarding its pathogenesis is that it is an …
adults. The most widely accepted hypothesis regarding its pathogenesis is that it is an …
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple …
Background Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the
central nervous system with a disabling progressive course. Chronic cerebrospinal venous …
central nervous system with a disabling progressive course. Chronic cerebrospinal venous …
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome …
S Zagaglia, S Balestrini, E Perticaroli, MC Danni… - Neurological …, 2013 - Springer
Some multiple sclerosis (MS) patients reported an improvement after percutaneous
transluminal angioplasty (PTA) for chronic cerebrospinal venous insufficiency (CCSVI) …
transluminal angioplasty (PTA) for chronic cerebrospinal venous insufficiency (CCSVI) …
Extracranial venous angioplasty is ineffective to treat MS
R Zivadinov, B Weinstock-Guttman - Nature Reviews Neurology, 2018 - nature.com
A randomized, double-blind, sham-controlled trial, Brave Dreams, has shown no clinical or
radiological benefit of percutaneous transluminal angioplasty (PTA) to correct chronic …
radiological benefit of percutaneous transluminal angioplasty (PTA) to correct chronic …
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis
Background Multiple sclerosis (MS) is a leading cause of neurological disability in young
adults. The most widely accepted hypothesis regarding its pathogenesis is that it is an …
adults. The most widely accepted hypothesis regarding its pathogenesis is that it is an …